Načítá se...
Radiolabeled bombesin derivatives for preclinical oncological imaging
Despite efforts, cancer is still one of the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases and 8.2 million cancer-related deaths each year, according to the World Health Organization. Among the strategies to reduce cancer progression and improving its ma...
Uloženo v:
| Vydáno v: | Biomed Pharmacother |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5331929/ https://ncbi.nlm.nih.gov/pubmed/28040598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopha.2016.12.083 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|